|
|
||||||||
The FASEB Journal, Vol 6, 2311-2322, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
SM Paul and RH Purdy
Section on Molecular Pharmacology, National Institute of Mental Health, Bethesda, Maryland 20892.
Neuroactive steroids are natural or synthetic steroids that rapidly alter the excitability of neurons by binding to membrane-bound receptors such as those for inhibitory and (or) excitatory neurotransmitters. The best-studied neuroactive steroids are a series of sedative-hypnotic 3 alpha-hydroxy ring A-reduced pregnane steroids that include the major metabolites of progesterone and deoxycorticosterone, 3 alpha-hydroxy-5 alpha-pregnan-20-one (allopregnanolone) and 3 alpha,21-dihydroxy-5 alpha-pregnan-20-one (allotetrahydroDOC), respectively. These 3 alpha-hydroxysteroids do not interact with classical intracellular steroid receptors but bind stereoselectively and with high affinity to receptors for the major inhibitory neurotransmitter in brain, gamma-amino-butyric acid (GABA). Biochemical and electrophysiological studies have shown that these steroids markedly augment GABA-activated chloride ion currents in a manner similar (but not identical) to that of anesthetic barbiturates. Several steroids have also been observed to have convulsant or proconvulsant properties, including the synthetic amidine 3 alpha- hydroxy-16-imino-5 beta-17-azaandrostan-11-one (RU5135) and the natural sulfate esters of pregnenolone and dehydroepiandrosterone. Several of these have been shown to be bicuculline or picrotoxin-like GABAA receptor antagonists. Examples of steroids that alter neuronal excitability rapidly by augmenting or inhibiting excitatory amino acid receptor-mediated responses have also been reported. Recently, allopregnanolone and allotetrahydroDOC have also been measured in brain and plasma where their levels have been shown to fluctuate in response to stress and during the estrous and menstrual cycles of rats and humans, respectively. Although the major fraction of allopregnanolone in tissue, including brain, is of adrenal and/or ovarian origin, appreciable levels of allopregnanolone can still be measured in the brains of adrenalectomized and/or oophorectomized animals. Receptor- active neurosteroids may represent an important class of neuromodulators that can rapidly alter central nervous system excitability via novel nongenomic mechanisms.
This article has been cited by other articles:
![]() |
M. Nin, F. Salles, L. Azeredo, A. Frazon, R. Gomez, and H. Barros Antidepressant effect and changes of GABAA receptor {gamma}2 subunit mRNA after hippocampal administration of allopregnanolone in rats J Psychopharmacol, July 1, 2008; 22(5): 477 - 485. [Abstract] [PDF] |
||||
![]() |
K. A. Grant, C. M. Helms, L. S. M. Rogers, and R. H. Purdy Neuroactive Steroid Stereospecificity of Ethanol-Like Discriminative Stimulus Effects in Monkeys J. Pharmacol. Exp. Ther., July 1, 2008; 326(1): 354 - 361. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Chen, Y. Miyamoto, K. Furuya, N. Mori, and M. Sokabe PREGS Induces LTP in the Hippocampal Dentate Gyrus of Adult Rats Via the Tyrosine Phosphorylation International Cooperative Research CREB Signaling J Neurophysiol, September 1, 2007; 98(3): 1538 - 1548. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. V. Belyaeva, S. V. Chetyrkin, A. L. Clark, N. V. Kostereva, K. S. SantaCruz, B. M. Chronwall, and N. Y. Kedishvili Role of Microsomal Retinol/Sterol Dehydrogenase-Like Short-Chain Dehydrogenases/Reductases in the Oxidation and Epimerization of 3{alpha}-Hydroxysteroids in Human Tissues Endocrinology, May 1, 2007; 148(5): 2148 - 2156. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. E. Alele and L. L. Devaud Sex Differences in Steroid Modulation of Ethanol Withdrawal in Male and Female Rats J. Pharmacol. Exp. Ther., January 1, 2007; 320(1): 427 - 436. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tasker, S. Di, and R. Malcher-Lopes Rapid Glucocorticoid Signaling via Membrane-Associated Receptors Endocrinology, December 1, 2006; 147(12): 5549 - 5556. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. W. Yau, J. Noble, M. Graham, and J. R. Seckl Central Administration of a Cytochrome P450-7B Product 7{alpha}-Hydroxypregnenolone Improves Spatial Memory Retention in Cognitively Impaired Aged Rats J. Neurosci., October 25, 2006; 26(43): 11034 - 11040. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Paul Alcohol-sensitive GABA receptors and alcohol antagonists PNAS, May 30, 2006; 103(22): 8307 - 8308. [Full Text] [PDF] |
||||
![]() |
R. M. Kaminski, H. Marini, P. I. Ortinski, S. Vicini, and M. A. Rogawski The Pheromone Androstenol (5{alpha}-Androst-16-en-3{alpha}-ol) Is a Neurosteroid Positive Modulator of GABAA Receptors J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 694 - 703. [Abstract] [Full Text] [PDF] |
||||
![]() |
J M Torres and E Ortega Steroid 5{alpha}-reductase isozymes in the adult female rat brain: central role of dihydrotestosterone. J. Mol. Endocrinol., April 1, 2006; 36(2): 239 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bekker, R. Shah, D. Quartermain, Y.-S. Li, and T. Blanck Isoflurane preserves spatial working memory in adult mice after moderate hypoxia. Anesth. Analg., April 1, 2006; 102(4): 1134 - 1138. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Erden, Z. Yangin, K. Erkalp, H. Delatioglu, F. Bahceci, and A. Seyhan Increased Progesterone Production During the Luteal Phase of Menstruation May Decrease Anesthetic Requirement Anesth. Analg., October 1, 2005; 101(4): 1007 - 1011. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Petrovic, M. Sedlacek, M. Horak, H. Chodounska, and L. Vyklicky Jr 20-Oxo-5{beta}-Pregnan-3{alpha}-yl Sulfate Is a Use-Dependent NMDA Receptor Inhibitor J. Neurosci., September 14, 2005; 25(37): 8439 - 8450. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schwabe, C. Gavrilovici, D. C. McIntyre, and M. O. Poulter Neurosteroids Exhibit Differential Effects on mIPSCs Recorded From Normal and Seizure Prone Rats J Neurophysiol, September 1, 2005; 94(3): 2171 - 2181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Tasker, S. Di, and R. Malcher-Lopes Rapid Central Corticosteroid Effects: Evidence for Membrane Glucocorticoid Receptors in the Brain Integr. Comp. Biol., August 1, 2005; 45(4): 665 - 671. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, Z.-X. Yao, and V. Papadopoulos Cytochrome P450 17{alpha} Hydroxylase/17,20 Lyase (CYP17) Function in Cholesterol Biosynthesis: Identification of Squalene Monooxygenase (Epoxidase) Activity Associated with CYP17 in Leydig Cells Mol. Endocrinol., July 1, 2005; 19(7): 1918 - 1931. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Wiltgen, M. J. Sanders, C. Ferguson, G. E. Homanics, and M. S. Fanselow Trace fear conditioning is enhanced in mice lacking the {delta} subunit of the GABAA receptor Learn. Mem., May 1, 2005; 12(3): 327 - 333. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. I. Butterfield, K. M. Stechuchak, K. M. Connor, J. R.T. Davidson, C. Wang, C. L. MacKuen, A. M. Pearlstein, and C. E. Marx Neuroactive Steroids and Suicidality in Posttraumatic Stress Disorder Am J Psychiatry, February 1, 2005; 162(2): 380 - 382. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Mody Aspects of the homeostaic plasticity of GABAA receptor-mediated inhibition J. Physiol., January 1, 2005; 562(1): 37 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Matsunaga, K. Ukena, E.-E. Baulieu, and K. Tsutsui 7{alpha}-Hydroxypregnenolone acts as a neuronal activator to stimulate locomotor activity of breeding newts by means of the dopaminergic system PNAS, December 7, 2004; 101(49): 17282 - 17287. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Liere, A. Pianos, B. Eychenne, A. Cambourg, S. Liu, W. Griffiths, M. Schumacher, J. Sjovall, and E.-E. Baulieu Novel lipoidal derivatives of pregnenolone and dehydroepiandrosterone and absence of their sulfated counterparts in rodent brain J. Lipid Res., December 1, 2004; 45(12): 2287 - 2302. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Storey and S. Kaufman Effect of pregnancy and 5{alpha}-pregnan-3{alpha}-ol-20-one on atrial receptor afferent discharge in rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2004; 287(6): R1427 - R1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pazol, M. E. Wilson, and K. Wallen Medroxyprogesterone Acetate Antagonizes the Effects of Estrogen Treatment on Social and Sexual Behavior in Female Macaques J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2998 - 3006. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Steckelbroeck, Y. Jin, S. Gopishetty, B. Oyesanmi, and T. M. Penning Human Cytosolic 3{alpha}-Hydroxysteroid Dehydrogenases of the Aldo-keto Reductase Superfamily Display Significant 3{beta}-Hydroxysteroid Dehydrogenase Activity: IMPLICATIONS FOR STEROID HORMONE METABOLISM AND ACTION J. Biol. Chem., March 12, 2004; 279(11): 10784 - 10795. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mano, T. Goto, M. Uchida, K. Nishimura, M. Ando, N. Kobayashi, and J. Goto Presence of protein-bound unconjugated bile acids in the cytoplasmic fraction of rat brain J. Lipid Res., February 1, 2004; 45(2): 295 - 300. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kishimoto, T. Hiroi, M. Shiraishi, M. Osada, S. Imaoka, S. Kominami, T. Igarashi, and Y. Funae Cytochrome P450 2D Catalyze Steroid 21-Hydroxylation in the Brain Endocrinology, February 1, 2004; 145(2): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. T. Bianchi and R. L. Macdonald Neurosteroids Shift Partial Agonist Activation of GABAA Receptor Channels from Low- to High-Efficacy Gating Patterns J. Neurosci., November 26, 2003; 23(34): 10934 - 10943. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Stell, S. G. Brickley, C. Y. Tang, M. Farrant, and I. Mody Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by {delta} subunit-containing GABAA receptors PNAS, November 25, 2003; 100(24): 14439 - 14444. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Belelli and M. B. Herd The Contraceptive Agent Provera Enhances GABAA Receptor-Mediated Inhibitory Neurotransmission in the Rat Hippocampus: Evidence for Endogenous Neurosteroids? J. Neurosci., November 5, 2003; 23(31): 10013 - 10020. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. G. Visser, D. R. H. Huntjens, P. H. van der Graaf, L. A. Peletier, and M. Danhof Mechanism-Based Modeling of the Pharmacodynamic Interaction of Alphaxalone and Midazolam in Rats J. Pharmacol. Exp. Ther., November 1, 2003; 307(2): 765 - 775. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. TORRES and E. ORTEGA Differential regulation of steroid 5{alpha}-reductase isozymes expression by androgens in the adult rat brain FASEB J, August 1, 2003; 17(11): 1428 - 1433. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. LOSEL, E. FALKENSTEIN, M. FEURING, A. SCHULTZ, H.-C. TILLMANN, K. ROSSOL-HASEROTH, and M. WEHLING Nongenomic Steroid Action: Controversies, Questions, and Answers Physiol Rev, July 1, 2003; 83(3): 965 - 1016. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott and Y. Higashi Cholesterol sulfate in human physiology: what's it all about? J. Lipid Res., July 1, 2003; 44(7): 1268 - 1278. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ji, A. Z. Murphy, and R. J. Traub Estrogen Modulates the Visceromotor Reflex and Responses of Spinal Dorsal Horn Neurons to Colorectal Stimulation in the Rat J. Neurosci., May 1, 2003; 23(9): 3908 - 3915. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. D. Strous, R. Maayan, R. Lapidus, R. Stryjer, M. Lustig, M. Kotler, and A. Weizman Dehydroepiandrosterone Augmentation in the Management of Negative, Depressive, and Anxiety Symptoms in Schizophrenia Arch Gen Psychiatry, February 1, 2003; 60(2): 133 - 141. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strohle, E. Romeo, F. di Michele, A. Pasini, B. Hermann, G. Gajewsky, F. Holsboer, and R. Rupprecht Induced Panic Attacks Shift {gamma}-Aminobutyric Acid Type A Receptor Modulatory Neuroactive Steroid Composition in Patients With Panic Disorder: Preliminary Results Arch Gen Psychiatry, February 1, 2003; 60(2): 161 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Uchida, E. Noda, Y. Kakazu, Y. Mizoguchi, N. Akaike, and J. Nabekura Allopregnanolone enhancement of GABAergic transmission in rat medial preoptic area neurons Am J Physiol Endocrinol Metab, December 1, 2002; 283(6): E1257 - E1265. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. G. Visser, W. W. F. T. Gladdines, P. H. van der Graaf, L. A. Peletier, and M. Danhof Neuroactive Steroids Differ in Potency but Not in Intrinsic Efficacy at the GABAA Receptor in Vivo J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 616 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Strott Sulfonation and Molecular Action Endocr. Rev., October 1, 2002; 23(5): 703 - 732. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q.-Y. Liu, Y. H. Chang, A. E. Schaffner, S. V. Smith, and J. L. Barker Allopregnanolone Activates GABAA Receptor/Cl- Channels in a Multiphasic Manner in Embryonic Rat Hippocampal Neurons J Neurophysiol, September 1, 2002; 88(3): 1147 - 1158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. G. Visser, C. J. G. M. Smulders, B. P. R. Reijers, P. H. van der Graaf, L. A. Peletier, and M. Danhof Mechanism-Based Pharmacokinetic-Pharmacodynamic Modeling of Concentration-Dependent Hysteresis and Biphasic Electroencephalogram Effects of Alphaxalone in Rats J. Pharmacol. Exp. Ther., September 1, 2002; 302(3): 1158 - 1167. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Iughetti, B. Predieri, L. Cobellis, S. Luisi, M. Luisi, S. Forese, F. Petraglia, and S. Bernasconi High Serum Allopregnanolone Levels in Girls with Precocious Puberty J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 2262 - 2265. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Matsui, M. Sakari, T. Sato, A. Murayama, I. Takada, M. Kim, K.-i. Takeyama, and S. Kato Transcriptional regulation of the mouse steroid 5{alpha}-reductase type II gene by progesterone in brain Nucleic Acids Res., March 15, 2002; 30(6): 1387 - 1393. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Wohlfarth, M. T. Bianchi, and R. L. Macdonald Enhanced Neurosteroid Potentiation of Ternary GABAA Receptors Containing the delta Subunit J. Neurosci., March 1, 2002; 22(5): 1541 - 1549. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Strohle, E. Romeo, F. di Michele, A. Pasini, A. Yassouridis, F. Holsboer, and R. Rupprecht GABAA Receptor-Modulating Neuroactive Steroid Composition in Patients With Panic Disorder Before and During Paroxetine Treatment Am J Psychiatry, January 1, 2002; 159(1): 145 - 147. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Pearson Murphy, S. I. Steinberg, F.-Y. Hu, and C. M. Allison Neuroactive Ring A-Reduced Metabolites of Progesterone in Human Plasma during Pregnancy: Elevated Levels of 5{alpha}-Dihydroprogesterone in Depressed Patients during the Latter Half of Pregnancy J. Clin. Endocrinol. Metab., December 1, 2001; 86(12): 5981 - 5987. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Laiprasert, R. L. Hamlin, and C. M. Heesch Afferent baroreceptor discharge in pregnant rats Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2456 - H2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Akwa, N. Ladurelle, D. F. Covey, and E.-E. Baulieu The synthetic enantiomer of pregnenolone sulfate is very active on memory in rats and mice, even more so than its physiological neurosteroid counterpart: Distinct mechanisms? PNAS, November 20, 2001; 98(24): 14033 - 14037. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Adkins, G. V. Pillai, J. Kerby, T. P. Bonnert, C. Haldon, R. M. McKernan, J. E. Gonzalez, K. Oades, P. J. Whiting, and P. B. Simpson alpha 4beta 3delta GABAA Receptors Characterized by Fluorescence Resonance Energy Transfer-derived Measurements of Membrane Potential J. Biol. Chem., October 12, 2001; 276(42): 38934 - 38939. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Paradiso, J. Zhang, and J. H. Steinbach The C Terminus of the Human Nicotinic {alpha}4{beta}2 Receptor Forms a Binding Site Required for Potentiation by an Estrogenic Steroid J. Neurosci., September 1, 2001; 21(17): 6561 - 6568. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. B. Javitt, Y. C. Lee, C. Shimizu, H. Fuda, and C. A. Strott Cholesterol and Hydroxycholesterol Sulfotransferases: Identification, Distinction from Dehydroepiandrosterone Sulfotransferase, and Differential Tissue Expression Endocrinology, July 1, 2001; 142(7): 2978 - 2984. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Nadeson and C. S. Goodchild Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically Br. J. Anaesth., May 1, 2001; 86(5): 704 - 708. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. S. Goodchild, A. Robinson, and R. Nadeson Antinociceptive properties of neurosteroids IV: pilot study demonstrating the analgesic effects of alphadolone administered orally to humans Br. J. Anaesth., April 1, 2001; 86(4): 528 - 534. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Steckelbroeck, M. Watzka, R. Reichelt, V. H. J. Hans, B. Stoffel-Wagner, D. D. Heidrich, J. Schramm, F. Bidlingmaier, and D. Klingmüller Characterization of the 5{{alpha}}-Reductase-3{{alpha}}-Hydroxysteroid Dehydrogenase Complex in the Human Brain J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1324 - 1331. [Abstract] [Full Text] |
||||
![]() |
D. Zhu, M. D. Wang, T. Backstrom, and G. Wahlstrom Evaluation and comparison of the pharmacokinetic and pharmacodynamic properties of allopregnanolone and pregnanolone at induction of anaesthesia in the male rat Br. J. Anaesth., March 1, 2001; 86(3): 403 - 412. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Terasawa and D. L. Fernandez Neurobiological Mechanisms of the Onset of Puberty in Primates Endocr. Rev., February 1, 2001; 22(1): 111 - 151. [Abstract] [Full Text] |
||||
![]() |
R. E. NAPPI, F. PETRAGLIA, S. LUISI, F. POLATTI, C. FARINA, and A. R. GENAZZANI Serum Allopregnanolone in Women With Postpartum "Blues" Obstet. Gynecol., January 1, 2001; 97(1): 77 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Orchinik, S. S. Carroll, Y.-H. Li, B. S. McEwen, and N. G. Weiland Heterogeneity of Hippocampal GABAA Receptors: Regulation by Corticosterone J. Neurosci., January 1, 2001; 21(1): 330 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Falkenstein, H.-C. Tillmann, M. Christ, M. Feuring, and M. Wehling Multiple Actions of Steroid Hormones---A Focus on Rapid, Nongenomic Effects Pharmacol. Rev., December 1, 2000; 52(4): 513 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. K. Singh, B. D. Schultz, J. A. Katzenellenbogen, E. M. Price, R. J. Bridges, and N. A. Bradbury Estrogen Inhibition of Cystic Fibrosis Transmembrane Conductance Regulator-Mediated Chloride Secretion J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 195 - 204. [Abstract] [Full Text] |
||||
![]() |
|